Webcasts & Presentations
Upcoming Events
| Date | Event Details | Remind me |
|---|---|---|
|
May 26, 2021 at 10:00 AM EDT
|
UBS Global Healthcare Virtual Conference
Anat Ashkenazi, Senior Vice President and Chief Financial Officer
|
|
|
August 3, 2021 at 9:00 AM EDT
|
Q2 2021 Earnings Call
|
|
|
October 26, 2021 at 9:00 AM EDT
|
Q3 2021 Earnings Call
|
|
|
February 3, 2022 at 9:00 AM EST
|
Q4 2021 Earnings Call
|
Archived Events
| Date | Event Details |
|---|---|
|
May 11, 2021 at 9:30 AM EDT
|
BofA Securities 2021 Virtual Health Care Conference
Mike Mason, Senior Vice President and President, Lilly Diabetes
|
|
May 4, 2021 at 10:30 AM EDT
|
Sustainability Call
Press Release 219.6 KB
|
|
April 27, 2021 at 9:00 AM EDT
|
Q1 2021 Earnings Call
Q1 2021 Lilly Press Release 206.8 KB
Q1 2021 Financial Workbook 126.8 KB
|
|
March 15, 2021 at 10:30 AM EDT
|
Donanemab Investor Presentation
|
|
March 9, 2021 at 9:45 AM EST
|
Barclays Global Healthcare Conference
Speakers: Patrik Jonsson, Senior Vice President; President, Lilly USA; and Chief Customer Officer
|
|
March 4, 2021 at 9:10 AM EST
|
Cowen 41st Annual Health Care Conference
Speakers: Dr. Dan Skovronsky Senior Vice President and Chief Scientific Officer
|
|
February 24, 2021 at 1:40 PM EST
|
SVB Leerink Global Healthcare Conference
Speakers: Ilya Yuffa, Senior Vice President and President, Lilly Bio-Medicines
|
|
February 12, 2021 at 11:00 AM EST
|
Guggenheim Healthcare Talks 2021 Oncology Day
Speakers: Anne White, Senior Vice President and President, Lilly Oncology and Jake Van Naarden, CEO, Loxo Oncology at Lilly
|
|
January 29, 2021 at 9:00 AM EST
|
Q4 2020 Earnings Call
Q4 2020 Lilly Press Release 227.5 KB
Q4 2020 Financial Workbook 136.9 KB
|
|
January 26, 2021 at 12:00 PM EST
|
SARS-CoV-2 Neutralizing Antibody Program Update
|
|
January 12, 2021 at 8:20 AM EST
|
39th Annual J.P. Morgan Healthcare Conference
Speaker: Dave Ricks, Chairman and Chief Executive Officer
|
|
December 15, 2020 at 8:30 AM EST
|
2021 Guidance Call
2021 Guidance Press Release 274.3 KB
|
|
December 1, 2020 at 2:40 PM EST
|
Evercore ISI 3rd Annual HealthCONx Conference
Mike Mason, Senior Vice President and President Lilly Diabetes & Connected Care
|
|
November 20, 2020 at 11:00 AM EST
|
tirzepatide SURPASS Program Overview
|
|
November 18, 2020 at 1:30 PM EST
|
Wolfe Research Virtual Healthcare Conference
Speaker: Joshua Smiley, Senior Vice President and Chief Financial Officer
|
|
November 16, 2020 at 11:00 AM EST
|
Bernstein’s Operational Decisions Conference
Speakers: Andrew Adams, Ph.D., Vice President, New Therapeutic Modalities and Scientific Leader for Lilly’s Anti-COVID-19 Platform, Jeff Emmick, M.D., Ph.D., Vice President, Diabetes Product Development, and Mark Mintun, M.D., Vice President, R&D – Neurodegeneration & Pain and President, Avid Radiopharmaceuticals |
|
October 27, 2020 at 9:00 AM EDT
|
Q3 2020 Earnings Call
Q3 2020 Lilly Press Release 249.3 KB
Q3 2020 Financial Workbook 134.9 KB
|
|
October 7, 2020 at 12:00 PM EDT
|
SARS-CoV 2 Neutralizing Antibody Program Update
|
|
September 21, 2020 at 3:00 PM EDT
|
Lilly Oncology Update at ESMO
|
